We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLG icon
301
SL Green Realty
SLG
$3.83B
$7.13M 0.04%
+104,914
New +$7.76M
RLAY icon
302
Relay Therapeutics
RLAY
$4B
$7.12M 0.04%
1,729,199
+636,494
+58% +$3.46M
NET icon
303
Cloudflare
NET
$96B
$7.07M 0.04%
65,633
-7,997
-11% -$781K
KB icon
304
KB Financial Group
KB
$39.5B
$7.05M 0.04%
4,279
WMB icon
305
Williams Companies
WMB
$85.8B
$6.96M 0.04%
128,553
+9,900
+8% +$534K
ORA icon
306
Ormat Technologies
ORA
$5.8B
$6.89M 0.04%
+101,747
New +$7.86M
SRPT icon
307
Sarepta Therapeutics
SRPT
$1.64B
$6.89M 0.04%
56,639
-2,869
-5% -$352K
COF icon
308
Capital One
COF
$128B
$6.87M 0.04%
38,510
+4,248
+12% +$735K
EWTX icon
309
Edgewise Therapeutics
EWTX
$4.28B
$6.78M 0.04%
253,965
-40,659
-14% -$1.29M
EXC icon
310
Exelon
EXC
$48.1B
$6.74M 0.04%
179,067
+27,975
+19% +$1.09M
WDAY icon
311
Workday
WDAY
$41.5B
$6.7M 0.04%
25,955
+1,861
+8% +$475K
AKAM icon
312
Akamai
AKAM
$15.6B
$6.6M 0.04%
68,994
+4,694
+7% +$460K
LKQ icon
313
LKQ Corp
LKQ
$6.72B
$6.59M 0.04%
179,414
-23,658
-12% -$904K
STLD icon
314
Steel Dynamics
STLD
$36.2B
$6.58M 0.04%
57,671
+1,206
+2% +$160K
HUM icon
315
Humana
HUM
$43.9B
$6.27M 0.04%
24,710
+15,833
+178% +$4.25M
LRN icon
316
Stride
LRN
$4.16B
$6.26M 0.04%
60,196
-13,338
-18% -$1.27M
OMC icon
317
Omnicom Group
OMC
$22.7B
$6.17M 0.04%
71,712
-41,468
-37% -$4.11M
AJG icon
318
Arthur J. Gallagher & Co
AJG
$69.1B
$6.12M 0.04%
21,564
+5,474
+34% +$1.59M
APO icon
319
Apollo Global Management
APO
$69B
$6.11M 0.04%
36,966
+1,142
+3% +$181K
TRV icon
320
Travelers Companies
TRV
$81.1B
$6.08M 0.04%
25,255
+132
+0.5% +$33K
NMRA icon
321
Neumora Therapeutics
NMRA
$306M
$6.05M 0.03%
571,027
-105,217
-16% -$1.26M
TGT icon
322
Target
TGT
$66.3B
$6.03M 0.03%
44,627
-68,257
-60% -$9.78M
SWTX
323
DELISTED
SpringWorks Therapeutics
SWTX
$5.93M 0.03%
164,015
-681,155
-81% -$23.8M
FDX icon
324
FedEx
FDX
$73B
$5.92M 0.03%
21,033
+709
+3% +$198K
SFM icon
325
Sprouts Farmers Market
SFM
$7.44B
$5.91M 0.03%
46,538
-43,941
-49% -$5.84M

Similar funds

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.